We are committed to finding a safe and effective therapy for food and pediatric allergy patients


Living with Peanut Allergy: Learn More

Latest News

DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age

Monthly information regarding the total number of voting rights and total number of shares of the Company 


20F- Form 2016